查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
器官移植诊断市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按组件、移植类型、技术、应用、终端用户、公司和地区划分
市场调查报告书
商品编码
1289654

器官移植诊断市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按组件、移植类型、技术、应用、终端用户、公司和地区划分

Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Transplant Type, By Technology, By Application, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在2023-2027年的预测期内，全球器官移植诊断市场预计将出现令人瞩目的增长。主要因素包括慢性疾病的日益流行，器官移植手术数量的增加，以及在移植诊断领域采用先进技术，这些都推动了市场的增长。器官移植是一种医疗技术，将一个器官从一个人的身体里取出来，放在接受者的身体里，以替代受损或缺失的器官。支持市场增长的其他因素包括：政府不断提高宣传力度，老年人口不断增加，器官衰竭的发病率不断上升，对分子诊断测试的需求很高，对医疗和诊断的投资和支出不断增加，器官移植手术的数量不断增加，器官移植诊断项目和新产品开发的不断推出，以及研究和开发活动的增加。

慢性疾病发病率的上升

全球范围内慢性疾病，如糖尿病、心血管疾病和其他疾病的发生率不断上升，促进了市场的增长。这是由于慢性病患者中器官衰竭的风险增加。根据世界卫生组织的数据，心血管疾病（CVDs）是全球死亡的主要原因，每年约有1790万人死亡。另外，老年人口更容易出现器官故障，特别是肝脏、心脏和肾脏，因此，反过来推动了市场的增长。根据美国政府关于器官捐赠和移植的信息，在2019年，63%的器官移植者是50岁或以上的人，21%的整体器官移植者是65岁及以上。

意识的提高和器官移植手术数量的增加

在过去的几年里，人们对器官移植的认识在不断提高，这也促进了市场的增长。由于大众的认识，人们开始进行器官移植手术，这也推动了市场的增长。政府和非政府组织采取了各种倡议，让人们了解器官移植。此外，器官移植手术数量的增加也推动了市场的增长。由于器官衰竭患者数量的增加，对移植手术的需求也在上升，这促进了市场的增长。根据卫生资源和服务管理局的数据，在2019年，美国约有112,568人需要器官移植。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告可提供以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球器官移植诊断市场的影响

第五章：客户的声音

第六章：全球器官移植诊断市场展望

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按组成部分（试剂盒和检测方法、消耗品、服务）分类
    • 按移植类型（实体器官移植与干细胞移植）分类
    • 按技术分类（分子技术、血清学、流式细胞仪、其他）
    • 按应用（临床诊断和/或转化研究）
    • 按终端用户（医院和移植中心，学术和研究机构，其他）
    • 按公司分类(2021年)
    • 按地区分类
  • 市场地图

第七章：北美器官移植诊断市场展望

  • 市场规模和预测
    • 按价值分类
  • 市场份额与预测
    • 按元件分类
    • 按移植类型
    • 按技术分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第8章：欧洲器官移植诊断市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按元件分类
    • 按移植类型
    • 按技术分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区器官移植诊断市场展望

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按元件分类
    • 按移植类型
    • 按技术分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美器官移植诊断市场展望

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按元件分类
    • 按移植类型
    • 按技术分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲器官移植诊断市场展望

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按元件分类
    • 按移植类型
    • 按技术分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 器官移植诊断法
    • 沙特阿拉伯 器官移植诊断法
    • 阿联酋 器官移植诊断法
    • 土耳其器官移植诊断法
    • 埃及 器官移植诊断法

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

  • Illumina, Inc.Thermo Fischer Scientific, Inc.雅培实验室，公司。Quest Diagnostics, Inc.F. Hoffmann-La Roche AG Bio-Rad Laboratories, Inc.Laboratory Corporation of America Holdings bioMerieux S.A. CareDx, Inc Immucor, Inc.

第十五章：战略建议

简介目录
Product Code: 13069

The global organ transplant diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing prevalence of chronic diseases, the increase in the number of organ transplantation surgeries, and the adoption of advanced technology in the field of transplant diagnostics, which are impelling the growth of the market. Organ transplantation is a medical technique in which an organ is removed from one body and placed in a recipient's body to substitute a damaged or missing organ. The other factors supporting the market's growth are, increasing government initiatives for spreading awareness, the rising geriatric population, the rising incidence of organ failure, high demand for molecular diagnostic tests, the surging investment and expenditure in healthcare and diagnostics, growing number of the organ transplant procedure, growing launch of programs & new product development in organ transplant diagnosis, and rise in research and development activities.

Rising Incidences of Chronic diseases

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe, are bolstering the growth of the market. This is attributed to the increased risk of organ failure among patients suffering from chronic diseases. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Also, the geriatric population is more prone to organ malfunction, especially the liver, heart, and kidney, thus, in turn, driving the growth of the market. As per the United States Government Information on Organ Donation and Transplantation, in 2019, 63 % of those who had organ transplants were aged 50 or older, and 21% of overall organ transplant individuals were aged 65 and above.

Increasing Awareness and Increase in the Number of Organ Transplantation Surgeries

Over the past few years, people are becoming more aware of organ transplantation, which is augmenting the growth of the market. Owing to the awareness among the masses, people are going for organ transplantation surgeries, which is fueling the growth of the market. Various initiatives are taken by the government and non-government organizations to make people aware of organ transplantation. Moreover, the rise in number of organ transplantation surgeries is fueling the growth of the market. Owing to the increase in the number of patients with organ failure, the demand for transplant procedures is rising, which is facilitating the growth of the market. According to Health Resources and Services Administration, in 2019, about 112,568 people in the U.S. required organ transplantation.

Market Segmentation

The global organ transplant diagnostics market is segmented into component, transplant type, technology, application, end-user, and company. Based on components, the market is divided into kits & assays, consumables, and services. Based on transplant type, the market is divided into solid organ transplants and stem cell transplants. Based on technology, the market is segmented into molecular technologies, serology, flow cytometry, and others. Based on application, the market is divided into clinical diagnostics and translational research. Based on end-user, the market is divided into hospitals & transplant centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the number of organ transplantation surgeries in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMerieux S.A., CareDx, Inc, and Immucor, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global organ transplant diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Diagnostics Market, By Component:

  • Kits & Assays
  • Consumables
  • Services

Organ Transplant Diagnostics Market, By Transplant Type:

  • Solid Organ Transplant
  • Stem Cell Transplant

Organ Transplant Diagnostics Market, By Technology:

  • Molecular Technologies
  • Serology
  • Flow Cytometry
  • Others

Organ Transplant Diagnostics Market, By Application:

  • Clinical Diagnostics
  • Translational Research

Organ Transplant Diagnostics Market, By End User:

  • Hospitals & Transplant Centers
  • Academic & Research Institutions
  • Others

Organ Transplant Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Organ Transplant Diagnostics Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Organ Transplant Diagnostics Market

5. Voice of Customer

6. Global Organ Transplant Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Kits & Assays, Consumables, Services)
    • 6.2.2. By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant)
    • 6.2.3. By Technology (Molecular Technologies, Serology, Flow Cytometry, Others)
    • 6.2.4. By Application (Clinical Diagnostics v/s Translational Research)
    • 6.2.5. By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Market Map

7. North America Organ Transplant Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Transplant Type
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organ Transplant Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Transplant Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Organ Transplant Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Transplant Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Organ Transplant Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Transplant Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Organ Transplant Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Transplant Type
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Organ Transplant Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Transplant Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Organ Transplant Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Transplant Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Organ Transplant Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Transplant Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Organ Transplant Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Transplant Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Organ Transplant Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Transplant Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Organ Transplant Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Transplant Type
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Organ Transplant Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Transplant Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Organ Transplant Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Transplant Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Organ Transplant Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Transplant Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Organ Transplant Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Transplant Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Organ Transplant Diagnostics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Transplant Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Organ Transplant Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Transplant Type
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Transplant Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Transplant Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Organ Transplant Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Transplant Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Organ Transplant Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Transplant Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Organ Transplant Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component
    • 11.2.2. By Transplant Type
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Organ Transplant Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Transplant Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Transplant Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Organ Transplant Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Transplant Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Organ Transplant Diagnostics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Transplant Type
        • 11.3.4.2.3. By Technology
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Organ Transplant Diagnostics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Transplant Type
        • 11.3.5.2.3. By Technology
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Illumina, Inc.
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Abbott Laboratories, Inc.
  • 14.4. Quest Diagnostics, Inc.
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Bio-Rad Laboratories, Inc.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. bioMerieux S.A.
  • 14.9. CareDx, Inc
  • 14.10. Immucor, Inc.

15. Strategic Recommendations